Parallel Advisors, LLC Sarepta Therapeutics, Inc. Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
A detailed history of Parallel Advisors, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 760 shares of SRPT stock, worth $14,614. This represents 0.0% of its overall portfolio holdings.
Number of Shares
760
Previous 993
23.46%
Holding current value
$14,614
Previous $63,000
80.95%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding SRPT
# of Institutions
507Shares Held
89MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$199 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$174 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$174 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$78.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$64.7 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.68B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...